Potential of Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Potential of Clinical Trials in Mexico

Potential of Clinical Trials in Mexico – Cohortias the CRO of LATAM

Clinical trials have long been regarded as the cornerstone of medical research and innovation. In recent years, Mexico has emerged as a promising destination for conducting clinical trials due to its diverse population, robust healthcare infrastructure, and regulatory advancements.

This blog explores the immense potential of clinical trials in Mexico, shedding light on the opportunities they present for medical advancement, economic growth, and improved patient outcomes.

Diverse and Representative Population

One of Mexico’s greatest strengths lies in its diverse and representative population. With over 126 million inhabitants from various ethnic backgrounds, Mexico offers a unique opportunity for researchers to conduct clinical trials that encompass a broad range of genetic and cultural diversity. This diversity enables the identification of population-specific responses to treatments, leading to more targeted and effective healthcare interventions.

Robust Healthcare Infrastructure

Mexico boasts a robust healthcare infrastructure, with a wide network of hospitals, research centers, and specialized clinics spread across the country. Renowned medical institutions and academic centers collaborate with pharmaceutical companies and research organizations to facilitate clinical trials.

This infrastructure not only supports the successful implementation of trials but also fosters collaboration between healthcare professionals, researchers, and industry experts, promoting knowledge exchange and scientific advancement.

Regulatory Advancements

In recent years, Mexico has made significant strides in improving its regulatory framework for clinical trials. Regulatory bodies such as the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) have streamlined approval processes, making it easier and faster for researchers to initiate and conduct trials. This progress has attracted multinational pharmaceutical companies, which view Mexico as an attractive destination for expanding their clinical research initiatives.

Cost-Effective Trials

Mexico offers a cost-effective environment for conducting clinical trials without compromising on quality. Lower operational costs, including site expenses, labor, and infrastructure, make Mexico an appealing option for both large and small pharmaceutical companies seeking to conduct trials. 

This cost advantage translates into increased access to cutting-edge treatments and therapies for Mexican patients, as well as the potential for economic growth through increased investment in the healthcare sector.

Potential of Clinical Trials in Mexico

Potential of Clinical Trials in Mexico

Collaboration and Knowledge Sharing

Clinical trials in Mexico foster collaboration and knowledge sharing among researchers, healthcare professionals, and patients. The participation of Mexican investigators in global clinical research projects enhances their expertise and knowledge, allowing them to contribute to the development of new medical interventions.

Furthermore, Mexican patients who enroll in clinical trials gain access to novel treatments that might otherwise be unavailable, while simultaneously contributing to scientific advancement and improved healthcare outcomes.

Stimulating Economic Growth

The potential of clinical trials to stimulate economic growth in Mexico should not be overlooked. As the country attracts more trials and pharmaceutical companies, it creates employment opportunities for healthcare professionals, researchers, and support staff.

The growth of clinical research centers and the associated infrastructure also drives investment in the healthcare sector, leading to technological advancements and increased access to quality healthcare services for the population at large.


Mexico’s growing prominence as a destination for clinical trials holds immense potential for medical advancement, economic growth, and improved patient outcomes. With its diverse population, robust healthcare infrastructure, regulatory advancements, and cost-effective environment, Mexico provides fertile ground for researchers and pharmaceutical companies to conduct groundbreaking trials.

By harnessing this potential, Mexico can become a vital player in the global landscape of medical research, contributing Improving healthcare outcomes and addressing the unique healthcare needs of the Mexican population are among the key benefits that clinical trials can bring to Mexico.

By conducting trials within the country, researchers gain insights into the effectiveness of treatments in the local context, considering factors such as genetics, lifestyle, and environmental influences. This localized knowledge contributes to the development of personalized medicine, where treatments can be tailored to individual patients, optimizing efficacy and minimizing side effects.

Potential of Clinical Trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Potential of Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Potential of Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Potential of Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Potential of Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Potential of Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Potential of Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Potential of Clinical Trials in Mexico

The Cohortias Team

Potential of Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Potential of Clinical Trials in Mexico

Network & Partnerships